299 related articles for article (PubMed ID: 11517046)
1. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
[TBL] [Abstract][Full Text] [Related]
2. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
3. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
[TBL] [Abstract][Full Text] [Related]
4. Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description.
Baker JA; Kornguth PJ; Floyd CE
AJR Am J Roentgenol; 1996 Apr; 166(4):773-8. PubMed ID: 8610547
[TBL] [Abstract][Full Text] [Related]
5. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
[TBL] [Abstract][Full Text] [Related]
6. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
7. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
9. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
10. Observer agreement using the ACR Breast Imaging Reporting and Data System (BI-RADS)-ultrasound, First Edition (2003).
Park CS; Lee JH; Yim HW; Kang BJ; Kim HS; Jung JI; Jung NY; Kim SH
Korean J Radiol; 2007; 8(5):397-402. PubMed ID: 17923782
[TBL] [Abstract][Full Text] [Related]
11. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
Seely JM; Nguyen ET; Jaffey J
Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
[TBL] [Abstract][Full Text] [Related]
12. Breast lesions detected on MR imaging: features and positive predictive value.
Liberman L; Morris EA; Lee MJ; Kaplan JB; LaTrenta LR; Menell JH; Abramson AF; Dashnaw SM; Ballon DJ; Dershaw DD
AJR Am J Roentgenol; 2002 Jul; 179(1):171-8. PubMed ID: 12076929
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
Margolin FR; Leung JW; Jacobs RP; Denny SR
AJR Am J Roentgenol; 2001 Sep; 177(3):559-64. PubMed ID: 11517047
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
[TBL] [Abstract][Full Text] [Related]
16. The BI-RADS breast magnetic resonance imaging lexicon.
Molleran V; Mahoney MC
Magn Reson Imaging Clin N Am; 2010 May; 18(2):171-85, vii. PubMed ID: 20494304
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
18. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
[TBL] [Abstract][Full Text] [Related]
19. Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound.
Lee HJ; Kim EK; Kim MJ; Youk JH; Lee JY; Kang DR; Oh KK
Eur J Radiol; 2008 Feb; 65(2):293-8. PubMed ID: 17531417
[TBL] [Abstract][Full Text] [Related]
20. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
